Business Standard

Dr Lal PathLabs Q1FY25 results: Net profit rises 28% to Rs 106 cr

Consolidated net profit rose 28 per cent to Rs 106 cr (around $13 million) for the quarter ended June 30, beating analysts' estimate of Rs 99.27 cr, per LSEG

Dr Pathlab, Dr lal pathlabs, medical test

The company, which operates about 300 labs in the country said its number of samples tested climbed 9.3 per cent | Image: Wikimedia Commons

Press Trust of India BENGALURU

Listen to This Article

Dr Lal PathLabs on Wednesday said its consolidated profit after tax increased 29 per cent to Rs 108 crore for the first quarter ending June 30, 2024.

The company had reported a profit after tax of Rs 84 crore in the April-June quarter of the last fiscal.

Revenue rose to Rs 602 crore for the period under review as compared to Rs 541 crore in the June quarter of last fiscal, Dr Lal PathLabs said in a statement.

The company said its board has approved an interim dividend of Rs 6 per share for 2024-25.

Shares of the company on Wednesday ended 3.17 per cent up at Rs 3,268.85 apiece on the BSE.

 


Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 07 2024 | 4:38 PM IST

Explore News